MOPIPP
MOPIPP Basic information
- Product Name:
- MOPIPP
- Synonyms:
-
- MOPIPP
- 2-Propen-1-one, 3-(5-methoxy-2-propyl-1H-indol-3-yl)-1-(4-pyridinyl)-, (2E)-
- CAS:
- 1485521-76-3
- MF:
- C20H20N2O2
- MW:
- 320.39
- Mol File:
- 1485521-76-3.mol
MOPIPP Chemical Properties
- Boiling point:
- 539.5±50.0 °C(Predicted)
- Density
- 1.191±0.06 g/cm3(Predicted)
- pka
- 16.02±0.30(Predicted)
MOPIPP Usage And Synthesis
Uses
MOPIPP is a novel indolebased chalcone, and vacuolin-1, is a non-lethal vacuoleinducing 2-propyl analog of MOMIPP.html" class="link-product" target="_blank">MOMIPP (HY-119624). MOPIPP induces cellular vacuolization and increases autophagosomes numbers. MOPIPP also triggers methuosis, and interrupts glucose uptake and glycolytic metabolism. MOPIPP can cross the blood-brain barrier and shows efficacy in suppressing tumor progression agaisnt glioblastoma cells[1][2][3].
in vivo
MOMIPP (80 mg/kg; i.p.; single dose) readily penetrates the bloodbrain barrier in female Swiss Webster Mice and (80 mg/kg; i.p.; every 24 h; 15 d) is effective in suppressing progression of intracerebral glioblastoma xenografts in female NCR-Foxn1 mice[3].
| Animal Model: | Intracerebral xenograft model in NCR-Foxn1 mice (female, 7-8 weeks, injected with U251- LUC cells)[3] |
| Dosage: | 80 mg/kg |
| Administration: | Intraperitoneal injection; every 24 hours for 15 days; monitored tumor progression by BLI on the days 7, 11, 15 |
| Result: | Significantly inhibited tumor progression. |
References
[1] Mbah NE, et al. Disruption of endolysosomal trafficking pathways in glioma cells by methuosis-inducing indole-based chalcones. Cell Biol Toxicol. 2017 Jun;33(3):263-282. DOI:10.1007/s10565-016-9369-2
[2] Li Z, et al. Vacuole-inducing compounds that disrupt endolysosomal trafficking stimulate production of exosomes by glioblastoma cells. Mol Cell Biochem. 2018 Feb;439(1-2):1-9. DOI:10.1007/s11010-017-3130-x
[3] Li Z, et al. The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma. BMC Cancer. 2019 Jan 16;19(1):77. DOI:10.1186/s12885-019-5288-y
MOPIPPSupplier
- Tel
- 15076683720
- klq@cw-bio.com
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
- Tel
- 17317130613
- 3358272972@qq.com
- Tel
- 4008200310
- marketing@tsbiochem.com
- Tel
- +17819995354
- marketing@targetmol.com